Lenvatinib/Everolimus Approved for Use in Advanced Kidney Cancer After Antiangiogenic Therapy

被引：0
|
作者：
Schuyler, Devon
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2016年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study
    Volkova, M., I
    Kalpinskiy, A. S.
    Borisov, P. S.
    Evsyukova, O., I
    Olshanskaya, A. S.
    Matveev, V. B.
    Alekseev, B. Ya
    Peganova, E., V
    Nasretdinov, A. F.
    Lymar, E., V
    Ovchinnikova, E. G.
    Sveklina, T. A.
    Usynin, E. A.
    Abdelgafur, A. M.
    Tararova, E. A.
    Shumova, L. M.
    Belenkov, A. S.
    Dolgov, I. Yu
    Ponomareva, N. G.
    Evstigneeva, I., V
    Ivanov, A. N.
    Isaev, A. R.
    Leonenkov, R., V
    Meskikh, A., V
    Mukhitova, M. R.
    Orlova, S. A.
    Teslenok, I., V
    Shegurova, M. M.
    Aivazov, M. T.
    Amoev, Z., V
    Babina, K. G.
    Vorontsova, A. A.
    Karabina, E., V
    Kirdakova, N., V
    Shumskaya, I. E.
    Kolesnikov, G. P.
    Kuzmina, E. S.
    Latipova, D. Kh
    Lyutova, E. S.
    Fael, M. M.
    Chugarova, A. N.
    Antipin, A. S.
    ONKOUROLOGIYA, 2021, 17 (01): : 31 - 44
  • [42] BEYOND THE BORDER: THE USE OF LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA AFTER DIFFERENT TREATMENT LINES: A RETROSPECTIVE ANALYSIS
    Jefremow, A.
    Wiesmueller, M.
    Rouse, R. A.
    Dietrich, P.
    Kremer, A. E.
    Waldner, M. J.
    Neurath, M. F.
    Siebler, J.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 71 (05): : 717 - 728
  • [43] Combination of antiangiogenic therapy using the mTOR inhibitor RAD001 (everolimus) and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: Dose-finding study
    Joka, Mareile
    Boeck, Stefan Hubert
    Hosius, Christian
    Decroix, Laetitia
    May, Christoph
    Alberter, Barbara
    Pustowka, Anette
    Heinemann, Volker
    Bruns, Christiane
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [44] Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer
    Sukumar, Jasmine Singh
    Moore, William
    Khan, Saad A.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019, 6 (04)
  • [45] Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy
    Shigeto Ueda
    Toshiaki Saeki
    Breast Cancer, 2014, 21 : 776 - 779
  • [46] A pivotal role of interdisciplinary team medicine in lenvatinib plus pembrolizumab therapy against advanced endometrial cancer
    Sonoda, Kenzo
    Sadamatsu, Yukiko
    Ishibashi, Yuka
    Okadome, Masao
    Katsuma, Shinichiro
    Nio, Ai
    Murakami, Takeshi
    Yamaguchi, Shinichiro
    Nagayama, Rina
    Ariyoshi, Kazuya
    Saito, Toshiaki
    ANNALS OF ONCOLOGY, 2023, 34 : S1463 - S1463
  • [47] Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy
    Ueda, Shigeto
    Saeki, Toshiaki
    BREAST CANCER, 2014, 21 (06) : 776 - 779
  • [48] Use of Negative Pressure Wound Therapy Systems after Radical Vulvectomy for Advanced Vulvar Cancer
    Quercia, Vittorio
    Saccone, Gabriele
    Raffone, Antonio
    Travaglino, Antonio
    Favale, Mariano
    D'Alessandro, Pietro
    Arduino, Bruno
    Carbone, Ilma Floriana
    Insabato, Luigi
    Ribuffo, Diego
    Zullo, Fulvio
    CANCER INVESTIGATION, 2020, 38 (8-9) : 531 - 534
  • [49] The role of antiangiogenic therapy in advanced gastro-esophageal cancer: a systematic review and meta-analysis
    Riesco-Martinez, M. C.
    Diaz-Serrano, A.
    Gomez-Martin, C.
    Adeva Alfonso, J.
    Sabater Cabrera, E.
    Garcia-Carbonero, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Evaluation of antiangiogenic therapy with bevacizumab in addition to neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
    McCammack, Erin
    Birhiray, Reumu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345